Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jan 11;13(4):2255.
doi: 10.4081/jphia.2022.2255. eCollection 2022 Dec 31.

High seroprevalence of anti-SARS-CoV-2 antibodies in the capital of Chad

Affiliations

High seroprevalence of anti-SARS-CoV-2 antibodies in the capital of Chad

Andrillene Laure Deutou Wondeu et al. J Public Health Afr. .

Abstract

Background: Since the start of the COVID-19 pandemic, Chad has had 7,417 confirmed cases and 193 deaths, one of the lowest in Africa.

Objective: This study assessed SARS-CoV-2 immunity in N'Djamena.

Methods: In August-October 2021, eleven N'Djamena hospitals collected outpatient data and samples. IgG antibodies against SARSCoV- 2 nucleocapsid protein were identified using ELISA. "Bambino Gesù" Laboratory, Rome, Italy, performed external quality control with chemiluminescence assay.

Results: 25-34-year-old (35.2%) made up the largest age group at 31.9±12.6 years. 56.4% were women, 1.3 women/men. The 7 th district had 22.5% and the 1st 22.3%. Housewives and students dominated. Overall seroprevalence was 69.5% (95% CI: 67.7-71.3), females 68.2% (65.8-70.5) and males 71.2% (68.6-73.8). >44-year-old had 73.9% seroprevalence. Under-15s were 57.4% positive. Housewives (70.9%), civil servants (71.5%), and health workers (9.7%) had the highest antibody positivity. N'Djamena's 9 th district had 73.1% optimism and the 3rd district had 52.5%. Seroprevalences were highest at Good Samaritan Hospital (75.4%) and National General Referral Hospital (74.7%).

Conclusion: Our findings indicate a high circulation of SARSCoV- 2 in N'Djamena, despite low mortality and morbidity after the first two COVID-19 pandemic waves. This high seroprevalence must be considered in Chad's vaccine policy.

Keywords: Anti nucleocapsid antibodies; COVID-19; N’Djamena community; SARS-CoV-2; Seroprevalence.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
General characteristics of participants. (A) The age of the participants grouped by age range; The <15-year-olds were the least numerous, while the 25-34-year-olds were the most represented. (B) Districts organised into 10 circuits; this figure represents the frequency of participation in each district. (C) Socio-professional categories present in this study. (D) Symptoms related to COVTD-19 manifested by the participants in the months preceding data collection. (E) Frequency of blood group represents among the participants, 55.7% (1504) did not know their blood group. (F) Data collection site and samples, a total of 11 sites participated: Farcha provincial hospital and the military training hospital had the lowest participation rates. NRGH: National Referral General Hospital, GSH: Good Samaritan Hospital, MCH: Mother and Child Hospital, RH: Renaissance Hospital, CCH: Chad-China Hospital, NDAH: "Notre Dame des Apôtres" Hospital, FPH: Farcha Provincial Hospital, PH: Peace Hospital, KFH: King Faisal Hospital, TMH: Training Military Hospital, GH2: Guinebor II Hospital./

References

    1. Azevedo MJ. The State of Health System(s) in Africa: Challenges and Opportunities. Hist Perspect State Heal Heal Syst Africa, Vol II. 2017. [cited 2022 Apr 27];1. Available from: 10.1007/978-3-319-32564-4_1 - DOI
    1. Mboussou F, Ndumbi P, Ngom R, Kamassali Z, Ogundiran O, Van Beek J, et al. Infectious disease outbreaks in the African region: overview of events reported to the World Health Organization in 2018. Epidemiol Infect [Internet]. 2019. Nov 11 [cited 2022 Apr 28];147:e299. Available from: https://pubmed.ncbi.nlm.nih.gov/31709961 - PMC - PubMed
    1. Fenollar F, Mediannikov O. Emerging infectious diseases in Africa in the 21st century. New microbes new Infect. 2018. Nov 1 [cited 2022 Apr 28];26:S10–8. Available from: https://pubmed.ncbi.nlm.nih.gov/30402238 - PMC - PubMed
    1. Mennechet FJD, Dzomo GRT. Coping with COVID-19 in Sub-Saharan Africa: What Might the Future Hold? Virol Sin [Internet]. 2020. Dec 1 [cited 2022 Apr 28];35(6):875. Available from: https://pubmed.ncbi.nlm.nih.gov/3287045 - PMC - PubMed
    1. Njenga MK, Dawa J, Nanyingi M, Gachohi J, Ngere I, Letko M, et al. Why is There Low Morbidity and Mortality of COVID-19 in Africa? Am J Trop Med Hyg [Internet]. 2020. Aug 1 [cited 2022 Apr 27];103(2):564. Available from: https://pubmed.ncbi.nlm.nih.gov/32484156 - PMC - PubMed

LinkOut - more resources